Latitude - Lateral Lymph Node Attitude Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSahlgrenska University Hospital

About this trial

Patients with advanced rectal cancer can sometimes have suspected tumour affected lymph nodes outside the standard operating field. These patients often receive preoperative treatment before surgery. There is a lack of consensus on what to do if there is remaining suspicion of tumour affected lymph nodes after the preoperative treatment. Removal of the lymph nodes using a broader surgical field with dissection of the lateral side-wall is often suggested, but the oncologic outcome is uncertain, and so is the patient reported outcome in terms of side effects.

This study aims to study the surgical treatment of tumour affected lateral lymph nodes to understand what lymph nodes require removal, and what effect that will have on oncologic outcome and the patient's function and QoL.

Eligibility criteria

Qualifiers

18 years or older

written informed consent

adenocarcinoma verified tumour below ≤ 8 cm from anal verge measured by rectoscopy and/or MRI

clinical tumor (cT) stage cT3, cT4a or cT4b on MRI or

Disqualifiers

Not biopsy confirmed rectal cancer (adenocarcinoma)

Recurrent rectal cancer

Age below 18

Participation in other trials in conflict with the protocol and end-points of the Latitude study

Trial design

Treatments tested in this trial

  • Lateral lymph node dissection

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Sahlgrenska University Hospital

Lead sponsor

Göteborg University

Collaborator